Tag: united therapeutics

October 16, 2018

United Therapeutics and MannKind Announce Closing of License and Collaboration Agreement

United Therapeutics (Nasdaq: UTHR) and MannKind (Nasdaq: MNKD) announced the closing of their pending worldwide exclusive license and collaboration agreement...
April 30, 2018

United Therapeutics to Acquire SteadyMed

United Therapeutics (NASDAQ:UTHR) and SteadyMed (NASDAQ:STDY) announced today the signing of a definitive merger agreement under which United Therapeutics will...
April 6, 2018

Sorrento and Celularity to Start Anti-CD38 CAR-T Phase 1 Clinical Trial in Patients With Relapsed or Refractory Multiple Myeloma

Sorrento Therapeutics (NASDAQ:SRNE) and Celularity announced today that the companies have started screening patients for its leading CD38 chimeric antigen...
January 23, 2018

Cynata Executes MoU for Commercial Evaluation with Celularity

Australian stem cell and regenerative medicine company, Cynata Therapeutics (ASX:CYP), is pleased to announce that the Company has entered into a...
April 6, 2017

Cardiome's Partner SteadyMed Completes Clinical Study

Cardiome Pharma (NASDAQ:CRME, TSX:COM) announced its partner SteadyMed Therapeutics (NASDAQ:STDY) successfully completed a clinical validation study of Trevyent.
January 4, 2017

Biotech Outlook 2017: After the Storm

Deep breaths, biotech investors. 2016 was a rough one—but the year ahead looks bright.
November 13, 2016

5 Top NASDAQ Biotech Stocks: PTC Therapeutics Gains 88 Percent

Last week's top gainer was PTC Therapeutics followed by Cogentix Medical, Concordia International, Galectin Therapeutics and XOMA.